Genome-wide Association and Sequencing Studies on Colorectal Cancer
Overview
Authors
Affiliations
Colorectal cancer is a leading cause of morbidity and mortality worldwide. Understanding its genetic mechanisms is key to improving risk prediction, prognostication and treatment. Results from genome-wide association studies have engendered a growing list of colorectal cancer susceptibility genes whereas the application of genome-wide mutational analysis has enabled the depiction of mutational landscape of colorectal cancer at high resolution. The development of novel technologies, such as metagenomic and single-cell sequencing, is expected to have positive impact on future genetic studies. However, challenges remain to address the changing epidemiology of colorectal cancer, issues on genetic testing, and clinical utilization of genomic data.
Lin Y, Wang S, Fan Z, Xie J, Ding G, Liu Y Medicine (Baltimore). 2024; 103(18):e37991.
PMID: 38701321 PMC: 11062724. DOI: 10.1097/MD.0000000000037991.
Zheng X, Song J, Yu C, Zhou Z, Liu X, Yu J Signal Transduct Target Ther. 2022; 7(1):60.
PMID: 35221332 PMC: 8882672. DOI: 10.1038/s41392-022-00881-8.
Hiramoto H, Muramatsu T, Ichikawa D, Tanimoto K, Yasukawa S, Otsuji E Sci Rep. 2017; 7(1):4002.
PMID: 28638102 PMC: 5479822. DOI: 10.1038/s41598-017-04191-w.
Advances in targeted and immunobased therapies for colorectal cancer in the genomic era.
Seow H, Yip W, Fifis T Onco Targets Ther. 2016; 9:1899-920.
PMID: 27099521 PMC: 4821380. DOI: 10.2147/OTT.S95101.
Tang S, Wu W, Li X, Wong S, Wong N, Chan M Sci Rep. 2016; 6:24466.
PMID: 27080237 PMC: 4832245. DOI: 10.1038/srep24466.